000			02098 a2200577 4500
005			20250517104538.0
264		0	_c20171226
008			201712s 0 0 eng d
022			_a1569-8041
024	7		_a10.1093/annonc/mdw238 _2doi
040			_aNLM _beng _cNLM
100	1		_aLindemann, K
245	0	0	_aPoor concordance between CA-125 and RECIST at the time of disease progression in patients with platinum-resistant ovarian cancer: analysis of the AURELIA trial. _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _c08 2016
300			_a1505-10 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBevacizumab _xtherapeutic use
650	0	4	_aCA-125 Antigen _xgenetics
650	0	4	_aDisease Progression
650	0	4	_aDisease-Free Survival
650	0	4	_aDoxorubicin _xtherapeutic use
650	0	4	_aDrug Resistance, Neoplasm _xgenetics
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Recurrence, Local _xdrug therapy
650	0	4	_aOvarian Neoplasms _xdrug therapy
650	0	4	_aPlatinum _xtherapeutic use
650	0	4	_aPrognosis
650	0	4	_aResponse Evaluation Criteria in Solid Tumors
700	1		_aKristensen, G
700	1		_aMirza, M R
700	1		_aDavies, L
700	1		_aHilpert, F
700	1		_aRomero, I
700	1		_aAyhan, A
700	1		_aBurges, A
700	1		_aRubio, M J
700	1		_aRaspagliesi, F
700	1		_aHuizing, M
700	1		_aCreemers, G-J
700	1		_aLykka, M
700	1		_aLee, C K
700	1		_aGebski, V
700	1		_aPujade-Lauraine, E
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 27 _gno. 8 _gp. 1505-10
856	4	0	_uhttps://doi.org/10.1093/annonc/mdw238 _zAvailable from publisher's website
999			_c26218671 _d26218671